NR602 - WEEK 6 iHUMAN ANGELA CORTEZ
(BEHAVIORAL HEALTH)
Primary Care of the Childbearing (Chamberlain University) — 2026-2027 Update Exam
Developed By: Advanced Clinical Pediatric Division & Chamberlain Faculty Review Committee
Release Date: Academic Year 2026-2027 (Updated Midterm/Final Prep Bank)
Core focus: Adolescent Major Depressive Disorder (MDD), Co-occurring Metabolic Risks, and Suicide Prevention
Standards.
This practice test bank is constructed in direct alignment with the iHuman pediatric clinical encounter for Angela
Cortez (AC), a 17-year-old female presenting with chronic fatigue and clinical depression symptoms. Every question
is designed to enhance clinical reasoning, diagnostic accuracy, and pharmacological mastery in primary care.
Explanations draw directly from current clinical practice guidelines, screening criteria, and academic evidence to
ensure maximum student readiness.
EXECUTIVE DIAGNOSTIC GUIDELINE & STUDY MATRIX
Study Section Diagnostic Guidelines & High-Yield Core Concepts
1. Title & Subject NR602: Week 6 iHuman Angela Cortez (Behavioral Health)
Subject: Primary Care of the Childbearing (Chamberlain University)
2. Key Topics Adolescent Major Depressive Disorder (MDD), Suicide Risk Assessment, Differential
Diagnosis of Fatigue (Endocrine, Metabolic, Infectious, Sleep), Growth Chart Analysis,
Pharmacotherapy (SSRIs), and Confidentiality.
3. Learning Objectives Identify pediatric depression symptoms; evaluate suicide statistics and genders; screen for
comorbid risk factors; establish organic vs. psychiatric causes of fatigue; select
evidence-based therapies (fluoxetine + CBT).
4. Terminology Anhedonia: Inability to feel pleasure. Acanthosis Nigricans: Hyperpigmented plaques
indicating insulin resistance. Passive Suicidal Ideation: Wanting to 'disappear' without
active intent or plans.
5. Procedures Growth Chart Analysis: Plotting height, weight, and BMI percentiles (e.g., 92nd percentile
= overweight). Suicide Screening: Routine use of PHQ-A and Columbia-Suicide Severity
Rating Scale (C-SSRS) in high-risk patients.
6. Commonly Confused Normal Moodiness vs. MDD: Moodiness is brief/transient. MDD is persistent (>2 weeks),
pervasive, associated with somatic complaints, and significantly interferes with academic
and daily functioning.
7. Comorbidities Substance abuse, obesity, Type 2 diabetes risk (indicated by striae, family history, and
acanthosis nigricans), and future risk of bipolar transition in early-onset depression.
, NR602: WEEK 6 iHUMAN ANGELA CORTEZ (BEHAVIORAL HEALTH) 2026-2027 UPDATE EXAM
PART I: ADOLESCENT DEPRESSION & SUICIDE EPIDEMIOLOGY
Question 1: According to evidence-based statistics, what is the estimated prevalence of clinical
depression among adolescents at any given point in time?
A. 2%
B. 6%
C. 12%
D. 18%
ANSWER ■: B — 6%
Explanation: The prevalence of adolescent depression is estimated to be 6% at any given point in time. This
makes it a highly significant primary care issue, as it is a chronic and serious illness that is associated with high
rates of academic, social, and physical morbidity.
Question 2: In the United States, suicide is classified as which leading cause of death among
individuals between the ages of 10 and 24 years?
A. First leading cause
B. Second leading cause
C. Third leading cause
D. Fifth leading cause
ANSWER ■: C — Third leading cause
Explanation: Suicide is the third leading cause of death among people between the ages of 10 and 24, with
approximately 4,400 young lives lost each year in the United States. This high mortality underscores the critical
necessity of universal, routine suicide risk screenings in primary care settings.
Question 3: When evaluating adolescent gender differences regarding suicide, which of the following
statements is clinically accurate?
A. Females complete suicide more often than males; males attempt more often.
B. Males complete suicide more often than females; females attempt more often.
C. Males and females have equal rates of attempts, but males are more successful.
D. Females have both higher rates of attempts and higher rates of successful completion.
ANSWER ■: B — Males complete suicide more often than females; females attempt more often.
Explanation: Adolescent females attempt suicide more frequently than males (representing 64% vs. 36% of all
attempts). However, adolescent males are far more likely to be successful/complete suicide (representing 84% vs.
16% of completions) because they typically utilize more violent, immediate, and lethal means.
PRIMARY CARE OF THE CHILDBEARING Page 2 of 12 CHAMBERLAIN UNIVERSITY
(BEHAVIORAL HEALTH)
Primary Care of the Childbearing (Chamberlain University) — 2026-2027 Update Exam
Developed By: Advanced Clinical Pediatric Division & Chamberlain Faculty Review Committee
Release Date: Academic Year 2026-2027 (Updated Midterm/Final Prep Bank)
Core focus: Adolescent Major Depressive Disorder (MDD), Co-occurring Metabolic Risks, and Suicide Prevention
Standards.
This practice test bank is constructed in direct alignment with the iHuman pediatric clinical encounter for Angela
Cortez (AC), a 17-year-old female presenting with chronic fatigue and clinical depression symptoms. Every question
is designed to enhance clinical reasoning, diagnostic accuracy, and pharmacological mastery in primary care.
Explanations draw directly from current clinical practice guidelines, screening criteria, and academic evidence to
ensure maximum student readiness.
EXECUTIVE DIAGNOSTIC GUIDELINE & STUDY MATRIX
Study Section Diagnostic Guidelines & High-Yield Core Concepts
1. Title & Subject NR602: Week 6 iHuman Angela Cortez (Behavioral Health)
Subject: Primary Care of the Childbearing (Chamberlain University)
2. Key Topics Adolescent Major Depressive Disorder (MDD), Suicide Risk Assessment, Differential
Diagnosis of Fatigue (Endocrine, Metabolic, Infectious, Sleep), Growth Chart Analysis,
Pharmacotherapy (SSRIs), and Confidentiality.
3. Learning Objectives Identify pediatric depression symptoms; evaluate suicide statistics and genders; screen for
comorbid risk factors; establish organic vs. psychiatric causes of fatigue; select
evidence-based therapies (fluoxetine + CBT).
4. Terminology Anhedonia: Inability to feel pleasure. Acanthosis Nigricans: Hyperpigmented plaques
indicating insulin resistance. Passive Suicidal Ideation: Wanting to 'disappear' without
active intent or plans.
5. Procedures Growth Chart Analysis: Plotting height, weight, and BMI percentiles (e.g., 92nd percentile
= overweight). Suicide Screening: Routine use of PHQ-A and Columbia-Suicide Severity
Rating Scale (C-SSRS) in high-risk patients.
6. Commonly Confused Normal Moodiness vs. MDD: Moodiness is brief/transient. MDD is persistent (>2 weeks),
pervasive, associated with somatic complaints, and significantly interferes with academic
and daily functioning.
7. Comorbidities Substance abuse, obesity, Type 2 diabetes risk (indicated by striae, family history, and
acanthosis nigricans), and future risk of bipolar transition in early-onset depression.
, NR602: WEEK 6 iHUMAN ANGELA CORTEZ (BEHAVIORAL HEALTH) 2026-2027 UPDATE EXAM
PART I: ADOLESCENT DEPRESSION & SUICIDE EPIDEMIOLOGY
Question 1: According to evidence-based statistics, what is the estimated prevalence of clinical
depression among adolescents at any given point in time?
A. 2%
B. 6%
C. 12%
D. 18%
ANSWER ■: B — 6%
Explanation: The prevalence of adolescent depression is estimated to be 6% at any given point in time. This
makes it a highly significant primary care issue, as it is a chronic and serious illness that is associated with high
rates of academic, social, and physical morbidity.
Question 2: In the United States, suicide is classified as which leading cause of death among
individuals between the ages of 10 and 24 years?
A. First leading cause
B. Second leading cause
C. Third leading cause
D. Fifth leading cause
ANSWER ■: C — Third leading cause
Explanation: Suicide is the third leading cause of death among people between the ages of 10 and 24, with
approximately 4,400 young lives lost each year in the United States. This high mortality underscores the critical
necessity of universal, routine suicide risk screenings in primary care settings.
Question 3: When evaluating adolescent gender differences regarding suicide, which of the following
statements is clinically accurate?
A. Females complete suicide more often than males; males attempt more often.
B. Males complete suicide more often than females; females attempt more often.
C. Males and females have equal rates of attempts, but males are more successful.
D. Females have both higher rates of attempts and higher rates of successful completion.
ANSWER ■: B — Males complete suicide more often than females; females attempt more often.
Explanation: Adolescent females attempt suicide more frequently than males (representing 64% vs. 36% of all
attempts). However, adolescent males are far more likely to be successful/complete suicide (representing 84% vs.
16% of completions) because they typically utilize more violent, immediate, and lethal means.
PRIMARY CARE OF THE CHILDBEARING Page 2 of 12 CHAMBERLAIN UNIVERSITY
